July 26, 2013 5:50 AM | 1 min read |
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, this week announced that healthy energy shot 24K™ has earned a patent from the US government. Dr. Carl W. Hastings, Reliv's chief scientific officer and creator of 24K, made the announcement as part of opening night at Reliv's 25th Anniversary International Conference.“This patent validates the work our R&D team put into making 24K unlike any other energy product on the market,” Hastings said. “24K provides a healthy alternative to the high-caffeine, high-sugar energy shots that have become so prevalent in recent years. And with 24K, you not only get energy, but nutritional support for mental focus and stress relief as well.”The patent for 24K comes two years after the product was first introduced and was named the People's Choice for Favorite New Consumer Product by the American Business Awards.Cracking the Fatigue CycleEnergy drinks have surged in popularity in recent years, and health advocates have expressed concern about the excessive amounts of caffeine found in most of these products. The U.S.
See full press release
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.